Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Adenocarcinoma × Radiotherapy × Clear all

Phase

Phase 2 8 Phase NA 2 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 5 Esophageal Squamous Cell Carcinoma 5 Esophageal Neoplasms 5 Rectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Oligodendroglioma 2 Nasopharyngeal Carcinoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, T-Cell 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Astrocytoma 2 Anemia, Refractory, with Excess of Blasts 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1

Interventions

Oxaliplatin 2 Fluorouracil 2 rubitecan 1 nimotuzumab 1 halofantrine 1 gallium 68 PSMA-11 1 camrelizumab 1 apatinib 1 S 1 (combination) 1 Radiotherapy 1 Radiosurgery 1 Radiation 1 Photochemotherapy 1 Nadroparin 1 Heparin, Low-Molecular-Weight 1 Gastrectomy 1 Esophagectomy 1 Docetaxel 1 Cisplatin 1 Chemoradiotherapy 1 Capecitabine 1 CP protocol 1 Brachytherapy 1 Atrasentan 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01249352 2025-03-31

NICE

Eurofarma Laboratorios S.A.

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡